I just tried to read the transcript, particularly the Q+A portion. They are incapable of giving a clear, straight answer to any analyst question. The answers are mind numbing and not in a good way. Someone should teach them how to speak clearly. Better yet, some of them need to go.
Weren't we supposed to get 853 data this year? Now it's ASCO. They haven't met a timeline ever. It's really pathetic.
The old partner deals were terrible, low single digits on what could be a blockbuster Sanofi naked antibody. Sanofi owns the IP, so I doubt IMGN could design an ADC on their own with the molecule.
Our only hope is that Sanofi, or Roche make an offer because IMGN execs are totally clueless. IMO of course, read the transcript and let me know what you think.
the EPS beat was a one-time thing, so not sustainable. I was more interested in the emerging pipeline story, which is getting no value, or attention. At this price, ARNA is like a 2 year+ call option. Shorts have very little to gain and more to lose by not covering here.
IMO, not advice. Need to get refocused on work (the day job) and stop micromanaging this investment. Later to the shorts.
that garbage is really getting old, yea they are real trapped and scared. Have you seen the chart lately?
Let's face the facts, the stock price is in a terrible, negative trend DOWN. Shorts are winning. Jack and co seem to have no answers. This is not going well for longs. If smoking, or Belphen are not positive, ARNA will continue to go lower. If smoking results are positive price will recover back to $6+ Not only am I losing $, I am wasting a lot of time!
There really was no positive news announced, other than they converted a stock asset to cash and have 2 years of cash at the current high loss rate. This is getting a bit distressing. It might be time to admit, ARNA could be a loser. IMO, not advice,
No, they never get into any detail on the partnered drugs, very lazy in doing research, or communicating. Same old story, more clarity some day soon, lots of stammering/lacking detail that suggests any real, tangible progress. We need Sanofi and Roche to make bids to end the madness and send DJ and co into retirement. Sum of parts is clearly worth more than $10's, maybe $20 in the right hands.
it's certainly well attended. I listened to another call that started at 8:00 and Thomas Wei was on that call just before the ARNA call, so he's having a busy morning. Good to hear Jack address the stock sale. I missed the first part of the call, will have to listen again for more detail. It sounded like they were pretty energized and proactive on the Q&A portion. Smoking and Bel-phen are the next keys, Diabetes was mentioned as a longer term opportunity, will take longer, building it into the LT safety trial. Overall, I think it was a mild positive from what I heard.
Please don't call out Adam, it's foolish to P him off.
Are you lost? This is the IMGN MB. ARNA has $200MM in the bank, not IMGN. Not to worry, I am putting them into play. Bidding war coming between Sanofi and Roche :-) (in our dreams)
I am glad they sold stock (good timing) and at least deferred the need to issue more ARNA stock buy about 2 quarters, but costs are too high compared to product revenues. Sales are rising, but not fast enough to offset costs. ARNA still needs good news on the pipeline and, or the additional Bel trials, Personally, I would not buy into this oversold relief rally on news that they sold some stock. IMO, not advice. I just don't think any gains will hold for long given the shorts aggressiveness.
Some old story, info is coming, we are getting closer, costs are rising, we have plenty of cash, some day...What usually comes next is a secondary. They should make it clear they are NOT going to issue more stock any time soon. If they did that, the stock would stop going down. They are not that smart.
I do expect a miss, so they better have something positive to add. Hopefully, the miss is baked in at this point, but be prepared for more manipulation and negative headlines. They should have been preparing analysts in advance the expected loss is waaaay too low after accounting for the purchase price adjustment. Daily losses is getting real OLD!
most are on ignore along with both of the Henry's, real (pumper) and fake-Henry Fudster. Cleaning it up. No Jack and co need to give us something to get excited about!
they always post a fluffy PR that makes everything sound "exciting". Then the analysts ask detailed questions and the story breaks down, there's some mumbling, bumbling, words come out, but they have no meaning and then the stock sinks. Nothing but lower lows and lower highs for 2 years. DJ and BOD need to get what they can and cash out, or hire a turnaround pro.
selling a winner to buy a loser is rarely a good strategy. Maybe on day CRIS will get turned around, or sell to Roche.
Not sure what they are thinking. No ideas where any unexpected, or substantial revenue will come from since there have been no new developments, no progress, no bus dev. If there's a surprise, I think it will be to the downside. Back to the $10's and rolling over, what a POS this stock has been in the past 2 years, really 25 years and counting.